Literature DB >> 26880448

Klotho connects intermedin1-53 to suppression of vascular calcification in chronic kidney disease.

Ming Chang Hu1.   

Abstract

Vascular calcification is one of the leading causes of death in chronic kidney disease (CKD) patients. Klotho protein encoded by the anti-aging gene, Klotho, and intermedin1-53 have both been shown to protect the vasculature from calcification in CKD. The study by Chang and colleagues links Klotho and intermedin1-53 in prevention of vascular calcification in CKD by showing that intermedin1-53 increased renal, vascular, and plasma Klotho, and reduced vascular calcification in CKD rats. Intermedin1-53 may be a novel therapeutic agent for CKD.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26880448      PMCID: PMC5590369          DOI: 10.1016/j.kint.2015.12.036

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.

Authors:  Ci-Di Chen; Sonia Podvin; Earl Gillespie; Susan E Leeman; Carmela R Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

Review 2.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

3.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

Review 4.  The pharmacology of adrenomedullin 2/intermedin.

Authors:  Yanguo Hong; Debbie L Hay; Remi Quirion; David R Poyner
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  Klotho deficiency causes vascular calcification in chronic kidney disease.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Carolyn Griffith; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

6.  Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.

Authors:  Rik Mencke; Geert Harms; Katarina Mirković; Joyce Struik; Joris Van Ark; Ellen Van Loon; Melissa Verkaik; Martin H De Borst; Clark J Zeebregts; Joost G Hoenderop; Marc G Vervloet; Jan-Luuk Hillebrands
Journal:  Cardiovasc Res       Date:  2015-06-26       Impact factor: 10.787

7.  Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.

Authors:  Jin Rui Chang; Jun Guo; Yue Wang; Yue Long Hou; Wei Wei Lu; Jin Sheng Zhang; Yan Rong Yu; Ming Jiang Xu; Xiu Ying Liu; Xiu Jie Wang; You Fei Guan; Yi Zhu; Jie Du; Chao Shu Tang; Yong Fen Qi
Journal:  Kidney Int       Date:  2016-01-28       Impact factor: 10.612

8.  Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.

Authors:  Yan Cai; Ming-Jiang Xu; Xu Teng; Ye Bo Zhou; Li Chen; Yi Zhu; Xian Wang; Chao Shu Tang; Yong Fen Qi
Journal:  Cardiovasc Res       Date:  2009-11-12       Impact factor: 10.787

9.  Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.

Authors:  Isabelle Six; Hirokazu Okazaki; Priscilla Gross; Joanna Cagnard; Cédric Boudot; Julien Maizel; Tilman B Drueke; Ziad A Massy
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  9 in total
  8 in total

1.  Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.

Authors:  Ming Chang Hu; Mingjun Shi; Nancy Gillings; Brianna Flores; Masaya Takahashi; Makoto Kuro-O; Orson W Moe
Journal:  Kidney Int       Date:  2017-01-25       Impact factor: 10.612

Review 2.  Potential application of klotho in human chronic kidney disease.

Authors:  Javier A Neyra; Ming Chang Hu
Journal:  Bone       Date:  2017-01-20       Impact factor: 4.398

Review 3.  Hypoxia-inducible factor signaling in vascular calcification in chronic kidney disease patients.

Authors:  Sidar Copur; Duygu Ucku; Mario Cozzolino; Mehmet Kanbay
Journal:  J Nephrol       Date:  2022-10-08       Impact factor: 4.393

Review 4.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

Review 5.  Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Xiang Lu; Ming Chang Hu
Journal:  Kidney Dis (Basel)       Date:  2016-11-17

6.  Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.

Authors:  Jing Chen; Xiaoyan Zhang; Han Zhang; Tongqiang Liu; Hui Zhang; Jie Teng; Jun Ji; Xiaoqiang Ding
Journal:  Int J Biol Sci       Date:  2016-09-15       Impact factor: 6.580

Review 7.  The role of klotho in chronic kidney disease.

Authors:  Di Zou; Wen Wu; Yan He; Sichao Ma; Ji Gao
Journal:  BMC Nephrol       Date:  2018-10-22       Impact factor: 2.388

Review 8.  Klotho, Aging, and the Failing Kidney.

Authors:  Sarah Buchanan; Emilie Combet; Peter Stenvinkel; Paul G Shiels
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-27       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.